NCT04310943 2024-03-06Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung AdenocarcinomaGuangzhou Institute of Respiratory DiseasePhase 2 Completed24 enrolled